Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation ; volume:8 ; number:1 ; day:13 ; month:12 ; year:2018 ; pages:1-8 ; date:12.2018
Scientific reports ; 8, Heft 1 (13.12.2018), 1-8, 12.2018
- Urheber
-
Ooi, Chee Y.
Syed, Saad A.
Rossi, Laura
Garg, Millie
Needham, Bronwen
Avolio, Julie
Young, Kelsey
Surette, Michael G.
Gonska, Tanja
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-36364-6
- URN
-
urn:nbn:de:101:1-2019012703503071948455
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ooi, Chee Y.
- Syed, Saad A.
- Rossi, Laura
- Garg, Millie
- Needham, Bronwen
- Avolio, Julie
- Young, Kelsey
- Surette, Michael G.
- Gonska, Tanja
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie